Le Lézard
Classified in: Science and technology
Subject: PLW

Fullpower®-AI Announces Issuance of Five New Patents, Enhancing Its Leadership in Sleep and Wellness Technologies


SANTA CRUZ, Calif., May 2, 2024 /PRNewswire/ -- Fullpower®-AI, a leader in sleep technology and wellness solutions, is proud to announce the issuance of five new U.S. patents that further enhance and expand its innovative product offerings. These patents underscore Fullpower®-AI's commitment to advancing the science of sleep and wellness through cutting-edge technology.

US Patent 11,972,775 - This patent introduces an innovative system for collecting sleep data in noisy environments. By integrating a noise source controller, the system strategically triggers data collection when noise levels reach a minimal baseline, allowing for an accurate assessment of sleep parameters, including distinctive sleep sounds. Issued on April 23, 2024, this patent emphasizes Fullpower®-AI's dedication to improving sleep quality regardless of environmental disturbances.

US Patent 11,963,770?Expanding the application of Fullpower®-AI's technology, this patent covers a non-contact sensor system for monitoring meditation. The system includes a specialized meditation surface equipped with a contactless biosensor. This setup assesses meditation quality and offers personalized feedback and recommendations to enhance the meditation experience. Issued simultaneously on April 23, 2024, it highlights the company's venture into holistic wellness solutions.

US Patent 11,963,792 - This patent provides a comprehensive solution for evaluating the sleep ecosystem of family units, including adults, children, and pets. By utilizing sensor data to identify each member and their sleep state, the system customizes the environment to promote optimal sleep across the household.

US Patent 11,918,525 - Focused on individual sleep enhancement, this patent details a system that guides users through a restful night by adjusting the sleep surface's firmness and temperature according to calculated optimal sleep states. Issued on January 30, 2024, it reflects Fullpower®-AI's innovative approach to personalizing sleep environments.

US Patent 11,883,188 - This patent introduces an advanced inductive sleep sensor capable of monitoring multiple sleepers simultaneously. The technology precisely analyzes and differentiates data from each sleeper to provide tailored sleep information, enhancing the understanding of shared sleeping dynamics.

"These patents represent significant technological advancements and reinforce our leadership in the sleep and wellness industries," said Philippe Kahn, CEO of Fullpower®-AI. "With these innovations, we continue to fulfill our mission of improving health and well-being through smarter, adaptive technologies that respond in real-time."

The issuance of these patents is a testament to Fullpower®-AI's ongoing commitment to innovation and excellence in health technology. For more information about Fullpower®-AI and its solutions, please visit fullpower-AI.com and Sleeptracker-AI.com

About Fullpower®-AI: Fullpower®-AI is the provider of a generative AI deep-learning biosensing platform. The Fullpower®-AI platform is a remote real-time biosensing cloud-to-edge solution vetted and successfully deployed in 60+ countries. Fullpower®-AI customers are in sleep, life sciences, health, wellness, and biotechnology. A portfolio of 135+ patents backs the platform. Fullpower®-AI is ISO 27001 certified.

For more information contact [email protected] 

SOURCE Fullpower


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: